113 related articles for article (PubMed ID: 8389526)
1. Transscleral iontophoresis of foscarnet.
Sarraf D; Equi RA; Holland GN; Yoshizumi MO; Lee DA
Am J Ophthalmol; 1993 Jun; 115(6):748-54. PubMed ID: 8389526
[TBL] [Abstract][Full Text] [Related]
2. Ocular iontophoretic supplementation of intravenous foscarnet therapy.
Yoshizumi MO; Roca JA; Lee DA; Lee G; Gomez I
Am J Ophthalmol; 1996 Jul; 122(1):86-90. PubMed ID: 8659602
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome.
Díaz-Llopis M; Chipont E; Sanchez S; España E; Navea A; Menezo JL
Am J Ophthalmol; 1992 Dec; 114(6):742-7. PubMed ID: 1334376
[TBL] [Abstract][Full Text] [Related]
4. Ocular toxicity of iontophoretic foscarnet in rabbits.
Yoshizumi MO; Lee DA; Sarraf DA; Equi RA; Verdon W
J Ocul Pharmacol Ther; 1995; 11(2):183-9. PubMed ID: 8564639
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal delivery of ganciclovir in rabbits by transscleral iontophoresis.
Lam TT; Fu J; Chu R; Stojack K; Siew E; Tso MO
J Ocul Pharmacol; 1994; 10(3):571-5. PubMed ID: 7836866
[TBL] [Abstract][Full Text] [Related]
6. Determination of ocular toxicity in multiple applications of foscarnet iontophoresis.
Yoshizumi MO; Dessouki A; Lee DA; Lee G
J Ocul Pharmacol Ther; 1997 Dec; 13(6):529-36. PubMed ID: 9436156
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis.
Li SK; Jeong EK; Hastings MS
Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1224-31. PubMed ID: 15037591
[TBL] [Abstract][Full Text] [Related]
8. Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis.
Grossman RE; Chu DF; Lee DA
Invest Ophthalmol Vis Sci; 1990 May; 31(5):909-16. PubMed ID: 2335452
[TBL] [Abstract][Full Text] [Related]
9. Transscleral and transcorneal iontophoresis of ketoconazole in the rabbit eye.
Grossman R; Lee DA
Ophthalmology; 1989 May; 96(5):724-9. PubMed ID: 2748126
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits.
López-Cortés LF; Pastor-Ramos MT; Ruiz-Valderas R; Cordero E; Uceda-Montañés A; Claro-Cala CM; Lucero-Muñoz MJ
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1024-8. PubMed ID: 11274081
[TBL] [Abstract][Full Text] [Related]
11. Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging.
Molokhia SA; Jeong EK; Higuchi WI; Li SK
Int J Pharm; 2007 Apr; 335(1-2):46-53. PubMed ID: 17236728
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits.
López-Cortés LF; Ruiz-Valderas R; Lucero-Muñoz MJ; Cordero E; Pastor-Ramos MT; Marquez J
Antimicrob Agents Chemother; 2000 Mar; 44(3):756-9. PubMed ID: 10681351
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome.
Pearson PA; Jaffe GJ; Ashton P
Am J Ophthalmol; 1993 May; 115(5):686-8. PubMed ID: 8387726
[No Abstract] [Full Text] [Related]
14. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
[TBL] [Abstract][Full Text] [Related]
15. Experimental transscleral iontophoresis of ciprofloxacin.
Yoshizumi MO; Cohen D; Verbukh I; Leinwand M; Kim J; Lee DA
J Ocul Pharmacol; 1991; 7(2):163-7. PubMed ID: 1919272
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal pharmacokinetics in rabbits of the foscarnet lipid prodrug: 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA).
Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Severson GM; Freeman WR
Curr Eye Res; 1999 Mar; 18(3):161-7. PubMed ID: 10342370
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients.
Taburet AM; Katlama C; Blanshard C; Zorza G; Gazzard D; Dohin E; Gazzard BG; Frostegard C; Singlas E
Antimicrob Agents Chemother; 1992 Sep; 36(9):1821-4. PubMed ID: 1329628
[TBL] [Abstract][Full Text] [Related]
18. Transscleral iontophoresis of dexamethasone.
Lam TT; Edward DP; Zhu XA; Tso MO
Arch Ophthalmol; 1989 Sep; 107(9):1368-71. PubMed ID: 2783069
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.
Eljarrat-Binstock E; Domb AJ; Orucov F; Frucht-Pery J; Pe'er J
Curr Eye Res; 2007; 32(7-8):639-46. PubMed ID: 17852187
[TBL] [Abstract][Full Text] [Related]
20. Toxicologic and pharmacokinetic analysis of intravitreal injections of foscarnet, either alone or in combination with ganciclovir.
Berthe P; Baudouin C; Garraffo R; Hofmann P; Taburet AM; Lapalus P
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1038-45. PubMed ID: 8125715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
